Corcept Therapeutics IncorporatedCORTNASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank29
3Y CAGR-8.7%
5Y CAGR-5.4%
Studio
Year-over-Year Change

Return on equity

3Y CAGR
-8.7%/yr
vs -7.3%/yr prior
5Y CAGR
-5.4%/yr
Recent deceleration
Acceleration
-1.4pp
Decelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
202515.38%-25.2%
202420.56%-1.8%
202320.95%+3.7%
202220.21%-32.5%
202129.94%+47.8%
202020.26%-20.2%
201925.37%-7.2%
201827.33%-59.6%
201767.61%+243.7%
201619.67%-